Literature DB >> 26033245

Hepatic NAD salvage pathway is enhanced in mice on a high-fat diet.

Melanie Penke1, Per S Larsen2, Susanne Schuster3, Morten Dall2, Benjamin A H Jensen4, Theresa Gorski5, Andrej Meusel6, Sandy Richter5, Sara G Vienberg2, Jonas T Treebak2, Wieland Kiess3, Antje Garten5.   

Abstract

Nicotinamide phosphoribosyltransferase (Nampt) is the rate-limiting enzyme for NAD salvage and the abundance of Nampt has been shown to be altered in non-alcoholic fatty liver disease. It is, however, unknown how hepatic Nampt is regulated in response to accumulation of lipids in the liver of mice fed a high-fat diet (HFD). HFD mice gained more weight, stored more hepatic lipids and had an impaired glucose tolerance compared with control mice. NAD levels as well as Nampt mRNA expression, protein abundance and activity were significantly increased in HFD mice. Enhanced NAD levels were associated with deacetylation of p53 and Nfκb indicating increased activation of Sirt1. Despite impaired glucose tolerance and increased hepatic lipid levels in HFD mice, NAD metabolism was significantly enhanced. Thus, improved NAD metabolism may be a compensatory mechanism to protect against negative impact of hepatic lipid accumulation.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Fatty liver; High-fat diet; Mouse; NAD; NAMPT

Mesh:

Substances:

Year:  2015        PMID: 26033245     DOI: 10.1016/j.mce.2015.05.028

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  17 in total

1.  Paediatric endocrinology: Can niacin supplementation protect against congenital malformations?

Authors:  Melanie Penke; Wieland Kiess
Journal:  Nat Rev Endocrinol       Date:  2017-10-11       Impact factor: 43.330

Review 2.  Modulating NAD+ metabolism, from bench to bedside.

Authors:  Elena Katsyuba; Johan Auwerx
Journal:  EMBO J       Date:  2017-08-07       Impact factor: 11.598

3.  Hypophosphatemia after Hepatectomy or Pancreatectomy: Role of the Nicotinamide Phosphoribosyltransferase.

Authors:  Jian Zheng; Ilya G Glezerman; Eran Sadot; Anjuli McNeil; Cristina Zarama; Mithat Gönen; John Creasy; Linda M Pak; Vinod P Balachandran; Michael I D'Angelica; Peter J Allen; Ronald P DeMatteo; T Peter Kingham; William R Jarnagin; Edgar A Jaimes
Journal:  J Am Coll Surg       Date:  2017-07-06       Impact factor: 6.113

4.  Mitochondrial function in liver cells is resistant to perturbations in NAD+ salvage capacity.

Authors:  Morten Dall; Samuel A J Trammell; Magnus Asping; Anna S Hassing; Marianne Agerholm; Sara G Vienberg; Matthew P Gillum; Steen Larsen; Jonas T Treebak
Journal:  J Biol Chem       Date:  2019-07-18       Impact factor: 5.157

Review 5.  Adipose tissue NAD+ biology in obesity and insulin resistance: From mechanism to therapy.

Authors:  Shintaro Yamaguchi; Jun Yoshino
Journal:  Bioessays       Date:  2017-03-15       Impact factor: 4.345

6.  Hepatic NAD(+) deficiency as a therapeutic target for non-alcoholic fatty liver disease in ageing.

Authors:  Can-Can Zhou; Xi Yang; Xia Hua; Jian Liu; Mao-Bing Fan; Guo-Qiang Li; Jie Song; Tian-Ying Xu; Zhi-Yong Li; Yun-Feng Guan; Pei Wang; Chao-Yu Miao
Journal:  Br J Pharmacol       Date:  2016-06-27       Impact factor: 8.739

7.  Exogenous supplemental NAD+ protect myocardium against myocardial ischemic/reperfusion injury in swine model.

Authors:  Xinrong Zhai; Wenzheng Han; Ming Wang; Shaofeng Guan; Xinkai Qu
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

Review 8.  Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease.

Authors:  Manoela Mota; Bubu A Banini; Sophie C Cazanave; Arun J Sanyal
Journal:  Metabolism       Date:  2016-03-03       Impact factor: 8.694

9.  Visfatin Regulates Inflammatory Mediators in Mouse Intestinal Mucosa Through Toll-Like Receptors Signaling Under Lipopolysaccharide Stress.

Authors:  Xin Xin Pang; Abdur Rahman Ansari; Wen Jie Yang; Xiao Yu Niu; Ling Dong; Hui Zhen Li; Fen Liang Xu; Zhe Wei Zhang; Ke Xiao; Song Hui
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2021-04-15       Impact factor: 4.291

10.  Pathogenesis of NASH: The Impact of Multiple Pathways.

Authors:  Mazen Noureddin; Arun J Sanyal
Journal:  Curr Hepatol Rep       Date:  2018-10-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.